Literature DB >> 16904116

Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals.

Nobukazu Ishizaka1, Yuko Ishizaka, Ryozo Nagai, Ei-Ichi Toda, Hideki Hashimoto, Minoru Yamakado.   

Abstract

Serum albumin is a maker of nutritional status and possesses antioxidative properties. Here, we have sought to investigate the mode of association between serum albumin levels, metabolic syndrome, and carotid atherosclerosis by analyzing the data of the cross-sectional data from 8143 individuals who underwent general health screening test. After adjusting for age, total cholesterol, and smoking status, the highest quartile of serum albumin (>or=4.7 g/dL) was associated with increased prevalence of metabolic syndrome with an odds ratio of 1.80 (95% CI 1.41-2.23, P<0.0001) in women, and 1.60 (95% CI 1.44-1.78, P<0.0001) in men, when compared to the lowest serum albumin quartile (<4.3g/dL). By contrast, when compared with the lowest quartile, the highest quartile of serum albumin was associated with reduced prevalence of carotid plaque with an odds ratio of 0.62 (95% CI 0.42-0.91, P<0.001) in women, and 0.76 (95% CI 0.62-0.93, P<0.01) in men, and for carotid intima-media thickening with an odds ratio of 0.57 (95% CI 0.35-0.94, P<0.05) in women, and 0.71 (95% CI 0.55-0.92, P<0.01) in men. Our data showed that higher serum albumin was inversely associated with the prevalence of early carotid atherosclerosis, although it was positively associated with the prevalence of metabolic syndrome. Whether these observations are in part explained by the antioxidative properties of albumin requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904116     DOI: 10.1016/j.atherosclerosis.2006.06.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  18 in total

1.  Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study.

Authors:  Setor K Kunutsor; Hassan Khan; Jari A Laukkanen
Journal:  Diabetologia       Date:  2015-02-14       Impact factor: 10.122

2.  Serum albumin is associated with peripheral nerve function in patients with type 2 diabetes.

Authors:  Lu Li; Bo Liu; Jingyi Lu; Lan Jiang; Yinan Zhang; Yingdi Shen; Congrong Wang; Weiping Jia
Journal:  Endocrine       Date:  2015-04-10       Impact factor: 3.633

3.  Identification of differentially expressed genes related to metabolic syndrome induced with high-fat diet in E3 rats.

Authors:  Xi Lan; Dongmin Li; Bo Zhong; Juan Ren; Xuan Wang; Qingzhu Sun; Yue Li; Lee Liu; Li Liu; Shemin Lu
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-06

4.  Association of the serum albumin level with prognosis in chronic kidney disease patients.

Authors:  Haiying Song; Cuimei Wei; Haofei Hu; Qijun Wan
Journal:  Int Urol Nephrol       Date:  2022-03-01       Impact factor: 2.266

5.  Serum albumin levels are associated with cardioembolic and cryptogenic ischemic strokes: Northern Manhattan Study.

Authors:  Wei-Hai Xu; Chuanhui Dong; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Stroke       Date:  2014-02-18       Impact factor: 7.914

6.  The association between serum albumin levels and metabolic syndrome in a rural population of Korea.

Authors:  Hye Min Cho; Hyeon Chang Kim; Ju-Mi Lee; Sun Min Oh; Dong Phil Choi; Il Suh
Journal:  J Prev Med Public Health       Date:  2012-03-31

7.  Serum albumin levels: a simple answer to a complex problem? Are we on the right track of assessing metabolic syndrome?

Authors:  Sohee Kim; Shinae Kang
Journal:  Endocrinol Metab (Seoul)       Date:  2013-03

8.  Association between Serum Albumin, Insulin Resistance, and Incident Diabetes in Nondiabetic Subjects.

Authors:  Ji Cheol Bae; Sung Hwan Seo; Kyu Yeon Hur; Jae Hyeon Kim; Myung-Shik Lee; Moon Kyu Lee; Won Young Lee; Eun Jung Rhee; Ki Won Oh
Journal:  Endocrinol Metab (Seoul)       Date:  2013-03-25

9.  Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.

Authors:  Leon Fisher; Wichat Srikusalanukul; Alexander Fisher; Paul Smith
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

10.  Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients?

Authors:  Fang Liu; Jing Shen; Jun Zhao; Hui Zeng; Lianxi Li; Jungong Zhao; Fengdi Lu; Yuqian Bao; Weiping Jia
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.